Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT02303639
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02303639
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Finland
- Registry status
- Unknown status
Technical summary
Registry record NCT02303639. Randomized; no masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
- Acronym
- MANTRA-VT
- Condition
- Myocardial Infarction
- Condition
- Ventricular Tachyarrhythmia
- Intervention (Procedure)
- Radiofrequency catheter ablation
- Intervention (Drug)
- Antiarrhythmic drug therapy
- Lead sponsor
- Central Finland Hospital District
- Collaborator
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct02303639- Content hash
1544cc779ed6647d27efb6a947095a8d24520c0e7dc9d6c3e402663781f95e59